Rare diseases
Investigational molecules
Locations
Back to France591 clinical trials in Brest, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceStudy on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors
FranceStudy on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
FranceStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer
FranceStudy of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer
FranceStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
FranceStudy of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression
FranceStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
FranceStudy on Xevinapant and Radiotherapy for High-Risk Head and Neck Cancer Patients Unable to Take High-Dose Cisplatin
FranceStudy of Nivolumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation
FranceStudy Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on head and neck squamous cell carcinoma, exploring innovative treatments combining radiotherapy with targeted therapies. Studies also examine new approaches for esophageal cancer and pancreatic adenocarcinoma.
Multiple trials are investigating novel drug combinations and immunotherapy approaches for various cancer types.
Comprehensive research into Sjögren's syndrome treatment options, including innovative biological therapies and histopathological studies. Additional focus on rheumatoid arthritis and novel therapeutic approaches.
Studies aim to understand disease mechanisms and evaluate new therapeutic options for autoimmune disorders.
Investigation of treatments for pulmonary arterial hypertension and heart failure prevention. Research includes innovative drug combinations and preventive approaches for cardiovascular conditions.
Focus on developing effective treatments for chronic cardiovascular and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
